World Anti-Doping Code Commentary Project

The first fully comprehensive resource for anti-doping practitioners, providing guidance along all steps of the doping control process. With topics ranging from signatory compliance to application of the sanctioning regime, the commentary will assist the anti-doping movement to achieve a more effective implementation and harmonized interpretation of the 2015 World Anti-Doping Code.

­

Avada includes a blog shortcode you can use anywhere on the site!

This blog shortcode was submitted by Markus, one of our 20,000+ Avada users! It just goes to show what an awesome community we have, everyone is willing to help and share ideas. Our first priority is to provide solutions to our users, and we are happy to do that. Dont wait, come be apart of it today!

Meldonium and Moral Fault: Five Lessons Learned from the Sharapova ITF Tribunal Decision

In Fall 2015, WADA announced its decision to add the anti-ischemic drug “Meldonium” to its Prohibited List with effect on 1 January 2016, after the Monitoring Program and observation period 2015 revealed “evidence of its use by athletes with the intention of enhancing performance” (Explanatory Notice to the 2016 List). [...]

Talk is Cheap: The Daiders CAS Award on the Evidence Needed for a Contaminated Supplement Defense

CAS Award: CAS 2014/A/3615, WADA v. Lauris Daiders, Jànis Daiders, and FIM, January 30, 2015 While the fact pattern in this case – the unexplained presence of a Prohibited Substance allegedly attributable to supplement contamination – is not out of the ordinary, the thoroughness of the legal discussion undertaken by [...]

The ISSF v. WADA CAS Award: Another Therapeutic Use Exemption Request for Beta Blockers Shot Down

CAS Award: CAS 2013/A/3437, International Shooting Sport Federation v. WADA,  December 18, 2014. The granting of Therapeutic Use Exemptions (“TUE”) is an important aspect of an Anti-Doping Organization’s daily activities. It is also the only way for Athletes to receive medical treatment while staying active in competitive sport when they [...]

By |August 10th, 2015|Therapeutic Use Exemptions|0 Comments

The Stewart CAS Award: “Paperwork” Violations and Principles Surrounding “Retrospective” Therapeutic Use Exemptions

CAS Award: CAS 2014/A/3876, Stewart v. FIM, April 27, 2015. FACTS James Stewart, a professional motocross and supercross rider, had been regularly taking the medication “Adderall” since 2012,[1] when he underwent an In-Competition Doping Control test on 12 April at the 2014 AMA Supercross FIM World Championship.[2] In May 2014, [...]

The Lallukka CAS Award: The End of an Unsettled Era for Human Growth Hormone Cases?

CAS Award: WADA v. Lallukka, CAS 2014/A/3488, November 20, 2014 FACTS In September 2011, the Finnish cross-country skier Juha Lallukka (the “skier”), a National-Level Athlete affiliated with the Finnish Ski Association, was subjected to an Out-of-Competition test. The analysis returned an Adverse Analytical Finding for recombinant human Growth Hormone (“rhGH”, [...]

Biological passports and the 2015 Code: Will four-year bans for blood doping become the new norm?

Download the Bekele Blog Post HERE CAS Award: Alemitu Bekele Degfa v. Turkish Athletics Federation & IAAF, CAS 2013/A/3080, March 14, 2014. In this award, recently published in the CAS bulletin, Alemitu Bekele Degfa – a long-distance runner of Turkish Nationality and Ethiopian origin – was found to have committed an [...]

By |February 3rd, 2015|Intentional violations|0 Comments